Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Talis Biomedical Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −7 vs. Q1 2022
- Shares held
- 14.9M
- −1.67M (−10.1%) vs. Q1 2022
- Total value
- $12.1M
- −$11.3M (−48.2%) vs. Q1 2022
- New holders
- 9
- 5 more added
- Sold out
- 16
- 17 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLIS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $26 |
| Q3 2024 | 2 | $460.4K |
| Q2 2024 | 18 | $6.84M |
| Q1 2024 | 18 | $6.93M |
| Q4 2023 | 18 | $5.93M |
| Q3 2023 | 19 | $4.27M |
| Q2 2023 | 22 | $5.27M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 27 | $5.60M |
| Q3 2022 | 29 | $8.59M |
| Q2 2022 | 35 | $12.1M |
| Q1 2022 | 45 | $23.6M |
| Q4 2021 | 47 | $70.2M |
| Q3 2021 | 38 | $119.2M |
| Q2 2021 | 43 | $184.0M |
| Q1 2021 | 45 | $269.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Talis Biomedical Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 7,624,835 | $6.19M | 0.04% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 2,820,073 | $2.29M | 0.03% | −915,164−24.5% | Reduced |
| Greenlight Capital Inc | 2,235,783 | $1.82M | 0.14% | 00.0% | Unchanged |
| Vanguard Group Inc | 553,373 | $450.0K | 0.00% | −59,059−9.6% | Reduced |
| Newtyn Management, LLC | 284,726 | $231.0K | 0.04% | +284,726 | New |
| Prelude Capital Management, LLC | 223,934 | $182.0K | 0.01% | −32,461−12.7% | Reduced |
| Millennium Management LLC | 201,913 | $164.0K | 0.00% | +201,913 | New |
| Morgan Stanley | 171,652 | $139.0K | 0.00% | +21,355+14.2% | Added |
| Geode Capital Management, LLC | 144,746 | $117.0K | 0.00% | −120,158−45.4% | Reduced |
| Renaissance Technologies LLC | 107,765 | $88.0K | 0.00% | +91,167+549.3% | Added |
| BlackRock Inc. | 102,576 | $84.0K | 0.00% | −718,417−87.5% | Reduced |
| Mercer Global Advisors Inc | 79,880 | $65.0K | 0.00% | +68,500+601.9% | Added |
| Ergoteles LLC | 69,424 | $56.0K | 0.00% | +69,424 | New |
| Deutsche Bank AG | 60,120 | $49.0K | 0.00% | +52,281+666.9% | Added |
| State Street Corp | 50,490 | $41.0K | 0.00% | −201,120−79.9% | Reduced |
| Citadel Advisors LLC | 42,242 | $34.0K | 0.00% | +42,242 | New |
| Northern Trust Corp | 27,860 | $22.0K | 0.00% | −95,901−77.5% | Reduced |
| Goldman Sachs Group Inc | 23,242 | $19.0K | 0.00% | +23,242 | New |
| Virtu Financial LLC | 20,061 | $16.0K | 0.00% | +20,061 | New |
| Two Sigma Investments, LP | 17,798 | $14.0K | 0.00% | −56,030−75.9% | Reduced |
| Susquehanna International Group, LLP | 12,508 | $10.0K | 0.00% | +1,703+15.8% | Added |
| M&T Bank Corp | 11,756 | $10.0K | 0.00% | +11,756 | New |
| Qube Research & Technologies Ltd | 11,058 | $9.00K | 0.00% | −36,409−76.7% | Reduced |
| Tudor Investment Corp Et Al | 10,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,382 | $1.00K | 0.00% | −2,203−61.5% | Reduced |
| Bank of America Corp | 161 | $0 | 0.00% | −36,797−99.6% | Reduced |
| New York State Common Retirement Fund | 175 | $0 | 0.00% | −5,900−97.1% | Reduced |
| Citigroup Inc | 134 | $0 | 0.00% | −3,660−96.5% | Reduced |
| Wells Fargo & Company | 105 | $0 | 0.00% | −2,967−96.6% | Reduced |
| UBS Group AG | 20 | $0 | 0.00% | −2,725−99.3% | Reduced |
| Royal Bank of Canada | 320 | $0 | 0.00% | −838−72.4% | Reduced |
| Simplex Trading, LLC | 64 | $0 | 0.00% | −1,000−94.0% | Reduced |
| Credit Suisse AG | 8 | $0 | 0.00% | +8 | New |
| First Horizon Advisors, Inc. | 582 | $0 | 0.00% | +582 | New |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −53,809−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −54,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −52,462−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −31,324−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,800−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,767−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −11,403−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,355−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −6,948−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −6,552−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3,441−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,803−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,074−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,077−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |